What to expect from pharma at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of…
What may be driving Eli Lilly shares lower — plus, oil, financial stocks rally
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
What’s next for the weight loss drug market: pills, rivals, insurance
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy,…
Trump pharmaceutical tariff threat lessens after Pfizer deal
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…
Global Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032
To read more about the latest highlights related to the thyroid gland disorder treatment market, get a snapshot…
Market Caps Weather Hit – Los Angeles Business Journal
L.A. County’s publicly traded companies have had a tough time as of late, thanks in large part to…